Xencor Names Chairman

Monrovia-based Xencor, a developer of biotherapeutics, said today that it has named Bruce Carter, Ph.D., most recently the Chief Executive Officer of ZymoGenetics, as Chairman of the firm's board of directors. Carter has also served as Corporate Executive Vice President and Chief Scientific Officer for Novo Nordisk A/S, where Xencor said he led the efforts to establish ZymoGenetics as an independent company. Carter also serves as Chairman of ZymoGenetics, and also sits on the boards of Dr. Reddy's Laboratories LImited, QLT Inc., and the TB Alliance.